End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study

被引:4
|
作者
Molaoa, Thabang T. [1 ]
Bisiwe, Feziwe B. [1 ]
Ndlovu, Kwazi C. Z. [2 ,3 ]
机构
[1] Univ Free State, Div Nephrol, Dept Internal Med, Bloemfontein, South Africa
[2] Univ Cape Town, Div Nephrol & Hypertens, Cape Town, South Africa
[3] Univ Cape Town, Kidney & Hypertens Res Unit, Cape Town, South Africa
关键词
Incidence rate; End-stage kidney disease; Kidney replacement therapy; Dialysis access; South Africa; SUB-SAHARAN-AFRICA; RENAL-DISEASE; PERITONEAL-DIALYSIS; HEALTH-CARE; TRANSPLANTATION; PREVENTION; PREVALENCE; OUTCOMES; OLDER; HIV;
D O I
10.1186/s12882-021-02387-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background End-stage kidney disease (ESKD) and the required kidney replacement therapy (KRT) are significant public health challenges for low-and-middle-income countries. The South African government adopted a KRT rationing policy to balance the growing need for KRT and scarce resources. We aimed to describe the epidemiology and KRT access in patients with ESKD referred to the main public sector hospital in the Free State Province, South Africa. Methods A retrospective study of adult patients with ESKD admitted to Universitas Academic Hospital for KRT, was conducted between 1 January 2016 and 31 December 2018. A review of the KRT committee decisions to offer or deny KRT based on the KRT rationing policy of the Free State was undertaken. Demographic information, KRT committee outcomes, laboratory test results, and clinical details were collected from assessment tools, KRT committee meeting diaries, and electronic hospital records. Results Of 363 patients with ESKD referred for KRT access, 96 with incomplete records were excluded and 267 were included in the analysis. Median patient age was 40 (interquartile range, 33-49) years, and male patients accounted for 56.2 % (150/267, p = 0.004) of the cohort. The average annual ESKD incidence was 49.9 (95 % confidence interval [CI], 35.8-64.0) per-million-population. The most prevalent comorbidities were hypertension (42.3 %; 113/267), human immunodeficiency virus (HIV) (28.5 %; 76/267), and diabetes mellitus (19.1 %; 51/267). The KRT access rate was 30.7 % (82/267), with annual KRT incidence rates of 8.05 (95 % CI, 4.98-11.1), 11.5 (95 % CI, 7.83-15.1), and 14.1 (95 % CI, 10.3-18.0) per-million-population in 2016, 2017, and 2018, respectively. Advanced organ dysfunction was the commonest reason recorded for KRT access denial (58.9 %; 109/185). Age (odds ratio [OR], 1.04; 95 % CI, 1.00-1.07; p = 0.024) and diabetes (OR, 5.04; CI, 1.69-15.03; p = 0.004) were independent predictors for exclusion from KRT, while hypertension (OR, 1.80; 1.06-3.04; p = 0.029) independently predicted advanced organ dysfunction resulting in KRT exclusion. Conclusions Non-communicable and communicable diseases, including hypertension, diabetes, and HIV, contributed to ESKD, highlighting the need for improved early prevention strategies to address a growing incidence rate. Two-thirds of ESKD patients were unable to access KRT, with age, diabetes mellitus, and advanced organ dysfunction being significant factors adversely affecting KRT access.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Associations of kidney tests at medical facilities and health checkups with incidence of end-stage kidney disease: a retrospective cohort study
    Yoshimura, Ryuichi
    Yamamoto, Ryohei
    Shinzawa, Maki
    Kataoka, Rie
    Ahn, Mina
    Ikeguchi, Nami
    Wakida, Natsuki
    Toki, Hiroshi
    Moriyama, Toshiki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Associations of kidney tests at medical facilities and health checkups with incidence of end-stage kidney disease: a retrospective cohort study
    Ryuichi Yoshimura
    Ryohei Yamamoto
    Maki Shinzawa
    Rie Kataoka
    Mina Ahn
    Nami Ikeguchi
    Natsuki Wakida
    Hiroshi Toki
    Toshiki Moriyama
    Scientific Reports, 11
  • [33] Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry
    Abd ElHafeez, Samar
    Kramer, Anneke
    Arici, Mustafa
    Arnol, Miha
    Asberg, Anders
    Bell, Samira
    Belliere, Julie
    Diaz Corte, Carmen
    Fernandez Fresnedo, Gema
    Hemmelder, Marc
    Heylen, Line
    Hommel, Kristine
    Kerschbaum, Julia
    Naumovic, Radomir
    Nitsch, Dorothea
    Santamaria, Rafael
    Finne, Patrik
    Palsson, Runolfur
    Pippias, Maria
    Resic, Halima
    Rosenberg, Mai
    Santiuste de Pablos, Carmen
    Segelmark, Marten
    Schwartz Sorensen, Soren
    Jose Soler, Maria
    Vidal, Enrico
    Jager, Kitty J.
    Ortiz, Alberto
    Stel, Vianda S.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (09) : 1449 - 1460
  • [34] End-Stage Kidney Disease: The Author Reply
    Manian, Farrin A.
    HEALTH AFFAIRS, 2015, 34 (11)
  • [35] End-stage renal disease in sarcoidosis of the kidney
    Tsiouris, N
    Kovacs, B
    Daskal, I
    Brent, LH
    Samuels, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05)
  • [36] Extracorporeal Techniques in End-Stage Kidney Disease
    Meijers, Bjorn
    Vega, Almudena
    Juillard, Laurent
    Kawanishi, Hideki
    Kirsch, Alexander H.
    Maduell, Francisco
    Massy, Ziad A.
    Mitra, Sandip
    Vanholder, Raymond
    Ronco, Claudio
    Cozzolino, Mario
    BLOOD PURIFICATION, 2023, 53 (05) : 248 - 262
  • [37] Diphenhydramine Use in End-Stage Kidney Disease
    Nguyen, Timothy
    Polyakova, Beatrice
    Cerenzio, John
    Ramilo, Josh Renzo
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (02) : E232 - E237
  • [38] End-Stage Kidney Disease and Dialysis in Pregnancy
    Oliverio, Andrea L.
    Hladunewich, Michelle A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2020, 27 (06) : 477 - 485
  • [39] A Boy with End-Stage Kidney Disease and Hypertriglyceridemia
    Raina, Manan
    Savita, S.
    Singh, Kanika
    Sethi, Sidharth K.
    INDIAN JOURNAL OF NEPHROLOGY, 2024, 34 (03) : 261 - 262
  • [40] Cardiorenal Syndrome in End-Stage Kidney Disease
    Tsuruya, Kazuhiko
    Eriguchi, Masahiro
    Yamada, Shunsuke
    Hirakata, Hideki
    Kitazono, Takanari
    BLOOD PURIFICATION, 2015, 40 (04) : 337 - 343